254 related articles for article (PubMed ID: 8043936)
1. Congenital dyserythropoietic anaemia type II (HEMPAS) and its molecular basis.
Fukuda MN
Baillieres Clin Haematol; 1993 Jun; 6(2):493-511. PubMed ID: 8043936
[TBL] [Abstract][Full Text] [Related]
2. HEMPAS disease: genetic defect of glycosylation.
Fukuda MN
Glycobiology; 1990 Sep; 1(1):9-15. PubMed ID: 2136385
[TBL] [Abstract][Full Text] [Related]
3. Incomplete synthesis of N-glycans in congenital dyserythropoietic anemia type II caused by a defect in the gene encoding alpha-mannosidase II.
Fukuda MN; Masri KA; Dell A; Luzzatto L; Moremen KW
Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7443-7. PubMed ID: 2217175
[TBL] [Abstract][Full Text] [Related]
4. HEMPAS. Hereditary erythroblastic multinuclearity with positive acidified serum lysis test.
Fukuda MN
Biochim Biophys Acta; 1999 Oct; 1455(2-3):231-9. PubMed ID: 10571015
[TBL] [Abstract][Full Text] [Related]
5. Congenital dyserythropoietic anemias.
Marks PW; Mitus AJ
Am J Hematol; 1996 Jan; 51(1):55-63. PubMed ID: 8571938
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS).
Denecke J; Kranz C; Nimtz M; Conradt HS; Brune T; Heimpel H; Marquardt T
Glycoconj J; 2008 May; 25(4):375-82. PubMed ID: 18166993
[TBL] [Abstract][Full Text] [Related]
7. Short report: erythrocyte membranes from a patient with congenital dyserythropoietic anaemia type I (CDA-I) show identical, although less pronounced, glycoconjugate abnormalities to those from patients with CDA-II (HEMPAS).
Zdebska E; Woźniewicz B; Adamowicz-Salach A; Kościelak J
Br J Haematol; 2000 Sep; 110(4):998-1001. PubMed ID: 11054095
[TBL] [Abstract][Full Text] [Related]
8. Defective glycosylation of erythrocyte membrane glycoconjugates in a variant of congenital dyserythropoietic anemia type II: association of low level of membrane-bound form of galactosyltransferase.
Fukuda MN; Masri KA; Dell A; Thonar EJ; Klier G; Lowenthal RM
Blood; 1989 Apr; 73(5):1331-9. PubMed ID: 2495036
[TBL] [Abstract][Full Text] [Related]
9. Primary defect of congenital dyserythropoietic anemia type II. Failure in glycosylation of erythrocyte lactosaminoglycan proteins caused by lowered N-acetylglucosaminyltransferase II.
Fukuda MN; Dell A; Scartezzini P
J Biol Chem; 1987 May; 262(15):7195-206. PubMed ID: 2953718
[TBL] [Abstract][Full Text] [Related]
10. Heterozygosity of CDAN II (HEMPAS) gene may be detected by the analysis of erythrocyte membrane glycoconjugates from healthy carriers.
Zdebska E; Mendek-Czajkowska E; Ploski R; Woêniewicz B; Koscielak J
Haematologica; 2002 Feb; 87(2):126-30. PubMed ID: 11836161
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and genetics of congenital dyserythropoietic anemias (CDA)].
Rössler J; Havers W
Klin Padiatr; 2000; 212(4):153-8. PubMed ID: 10994542
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional consequences of an N-glycosylation mutation (HEMPAS) affecting human erythrocyte membrane glycoproteins.
Kameh H; Landolt-Marticorena C; Charuk JH; Schachter H; Reithmeier RA
Biochem Cell Biol; 1998; 76(5):823-35. PubMed ID: 10353717
[TBL] [Abstract][Full Text] [Related]
13. Congenital dyserythropoietic anemia type II: exclusion of seven candidate genes.
Lanzara C; Ficarella R; Totaro A; Chen X; Roberto R; Perrotta S; Lasalandra C; Gasparini P; Iolascon A; Carella M
Blood Cells Mol Dis; 2003; 30(1):22-9. PubMed ID: 12667984
[TBL] [Abstract][Full Text] [Related]
14. Incompletely processed N-glycans of serum glycoproteins in congenital dyserythropoietic anaemia type II (HEMPAS).
Fukuda MN; Gaetani GF; Izzo P; Scartezzini P; Dell A
Br J Haematol; 1992 Dec; 82(4):745-52. PubMed ID: 1482662
[TBL] [Abstract][Full Text] [Related]
15. Carbohydrate-deficient glycoprotein syndrome type II. An autosomal recessive N-acetylglucosaminyltransferase II deficiency different from typical hereditary erythroblastic multinuclearity, with a positive acidified-serum lysis test (HEMPAS).
Charuk JH; Tan J; Bernardini M; Haddad S; Reithmeier RA; Jaeken J; Schachter H
Eur J Biochem; 1995 Jun; 230(2):797-805. PubMed ID: 7607254
[TBL] [Abstract][Full Text] [Related]
16. Congenital dyserythropoietic anemia type II: molecular basis and clinical aspects.
Iolascon A; D'Agostaro G; Perrotta S; Izzo P; Tavano R; Miraglia del Giudice B
Haematologica; 1996; 81(6):543-59. PubMed ID: 9009444
[TBL] [Abstract][Full Text] [Related]
17. Congenital dyserythropoietic anemias.
Wickramasinghe SN
Curr Opin Hematol; 2000 Mar; 7(2):71-8. PubMed ID: 10698292
[TBL] [Abstract][Full Text] [Related]
18. Golgi alpha-mannosidase II deficiency in vertebrate systems: implications for asparagine-linked oligosaccharide processing in mammals.
Moremen KW
Biochim Biophys Acta; 2002 Dec; 1573(3):225-35. PubMed ID: 12417404
[TBL] [Abstract][Full Text] [Related]
19. Glycoconjugate abnormalities in patients with congenital dyserythropoietic anaemia type I, II and III.
Zdebska E; Gołaszewska E; Fabijańska-Mitek J; Schachter H; Shalev H; Tamary H; Sandström H; Wahlin A; Kościelak J
Br J Haematol; 2001 Sep; 114(4):907-13. PubMed ID: 11564084
[TBL] [Abstract][Full Text] [Related]
20. Congenital dyserythropoietic anemia, type II with SEC23B exon 12 c.1385 A → G mutation, and pseudo-Gaucher cells in two siblings.
Sharma P; Das R; Bansal D; Trehan A
Hematology; 2015 Mar; 20(2):104-7. PubMed ID: 24801240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
